ECTS 2025 Congress
ECTS Congress is the annual meeting of the European Calcified Tissue society, the place where the best of scientific research and clinical practice meet. The Congress is the top conference in Europe to present and discuss musculoskeletal research. Listening to top opinion leaders and experts from Europe and around the world plus face-to-face discussions with your peers create numerous opportunities for networking and developing new research ideas and projects.
The event, take place 23th-26th May 2025, in Innsbruck, Austria.

The ECTS is offering you the opportunity to submit your Abstracts or Clinical Cases from 9 September 2024- 14 January 2025 23:59 CET.

Event summary

Event ECTS 2025 Congress
Date 23 – 26 May 2025
Venue Congress Innsbruck, Innsbruck, Austria
Abstract submission Submit your abstract
Registration Register here
Download Preliminary Programme
Contact
see more here
ERN BOND at ECTS 2025: Focus on Lifelong Needs in OI Care Some representatives from ERN BOND took part in the ECTS 2025 meeting held in Innsbruck in May. One of the key sessions was a dedicated workshop titled “Lifelong Needs in the Care for and Follow-up of Adults with Osteogenesis Imperfecta (OI)”. The workshop featured insightful discussion alongside a valuable patient perspective shared by the president of OIFE. Beyond this workshop, ECTS 2025 offered a rich program filled with presentations of great relevance to the ERN BOND community, reinforcing the network’s commitment to advancing rare bone disease knowledge and care.

ERN BOND at ECTS 2025: Focus on Lifelong Needs in OI Care

Some representatives from ERN BOND took part in the ECTS 2025 meeting held in Innsbruck in May. One of the key sessions was a dedicated workshop titled “Lifelong Needs in the Care for and Follow-up of Adults with Osteogenesis Imperfecta (OI)”. The workshop featured insightful discussion alongside a valuable patient perspective shared by the president of OIFE.

Beyond this workshop, ECTS 2025 offered a rich program filled with presentations of great relevance to the ERN BOND community, reinforcing the network’s commitment to advancing rare bone disease knowledge and care.